Pfizer stock price the Pfizer stock price is hovering near

The Pfizer stock price is hovering near $28.50, with intraday charts showing a tight range between $28.30 and $28. We'll examine how Pfizer's tariff exemption and direct-to-consumer discount platform with the U.S. government could impact the company's long-term outlook. The MFN deal with Pfizer comes a few days after Trump announced 100% tariffs on branded pharma products would come into effect on October 1, giving exemptions to companies that have a manufacturing presence in the US, or are currently building a manufacturing plant. However, White House officials have put the 100% tariffs on pharma products on hold, as it continues to finalize MFN negotiations with pharma companies. This means the 100% levy will not take effect yet and instead, the Trump administration is reported to begin preparing tariffs from 1 October. White House officials continue to explain that tariffs will apply to those that do not onshore manufacturing to the US and to those that do not participate in the MFN pricing policy, suggesting more pharma companies may fall in line to avoid the tariffs. The three-year grace period on tariffs is also attractive given that the grace period will end near towards the end of Trump’s second administration and the next US administration may not employ tariffs against pharma products.